White label ELPA - ClinicalTrials.eu

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Recruiting

3 1
Investigated diseases:
- Vitiligo
Investigated drugs:
- Ruxolitinib
+6
Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

Recruiting

2 1
Investigated diseases:
- Dry age-related macular degeneration
Investigated drugs:
- XELAFASLATIDE
+3
Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study of Tarlatamab and Temozolomide combination treatment in adolescents and adults with high grade brain tumors

Recruiting

1 1 1 1
Investigated diseases:
- Brain neoplasm
Investigated drugs:
- Tarlatamab
- Temozolomide
Study of drug combination therapy in children and adolescents with relapsed or refractory B-cell non-Hodgkin lymphoma using odronextamab, loncastuximab tesirine and rituximab

Recruiting

4 1 1 1
Investigated diseases:
- B-cell lymphoma recurrent
- B-cell lymphoma refractory
Investigated drugs:
Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Recruiting

3 1 1 1
Investigated diseases:
- Acute lymphocytic leukaemia
- Philadelphia positive acute lymphocytic leukaemia
Investigated drugs:
+2
Study of dostarlimab treatment before surgery in patients with stage II-III endometrial cancer with specific genetic markers

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
- Dostarlimab
Study of etentamig and iberdomide treatment for patients with relapsed or refractory multiple myeloma

Recruiting

1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Iberdomide
Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

Recruiting

3 1 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

Recruiting

2 1 1 1
Investigated diseases:
- Adenocarcinoma pancreas
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies